These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
567 related items for PubMed ID: 26867396
1. IMMUNOGENICITY AND SAFETY OF QUINVAXEM® (DIPHTHERIA, TETANUS, WHOLE-CELL PERTUSSIS, HEPATITIS B AND HAEMOPHILUS INFLUENZAE TYPE B VACCINE) GIVEN TO VIETNAMESE INFANTS AT 2 TO 4 MONTHS OF AGE. Huu TN, Phuong NT, Toan NT, Thang HV. Southeast Asian J Trop Med Public Health; 2015 Jul; 46(4):753-63. PubMed ID: 26867396 [Abstract] [Full Text] [Related]
2. Comparison of the immunogenicity and safety of pentavalent vaccine Quinvaxem in a compact prefilled auto-disabled (cPAD) injection system versus single-dose vials in healthy infants: a phase 3, open-label, randomized, parallel-group, non-inferiority study. Capeding MR, Alberto E, Versteilen A, Rauscher M, Bagchi P, Palacios PI. Int J Infect Dis; 2016 May; 46():71-8. PubMed ID: 26923083 [Abstract] [Full Text] [Related]
3. Primary and booster immunization with a diphtheria, tetanus, acellular pertussis, hepatitis B (DTPa-HBV) and Haemophilus influenzae type b (Hib) vaccine administered separately or together is safe and immunogenic. Marshall H, McIntyre P, Roberton D, Dinan L, Hardt K. Int J Infect Dis; 2010 Jan; 14(1):e41-9. PubMed ID: 19467896 [Abstract] [Full Text] [Related]
5. Reactogenicity and immunogenicity profiles of a novel pentavalent diphtheria-tetanus-whole cell pertussis-hepatitis B and Haemophilus influenzae type B vaccine: a randomized dose-ranging trial of the Hib tetanus-conjugate content. Hla KH, Thein SA, Aye A, Han HH, Bock HL, David MP, Schuerman L. Pediatr Infect Dis J; 2006 Aug; 25(8):706-12. PubMed ID: 16874170 [Abstract] [Full Text] [Related]
12. Combined DTP-HBV-HIB vaccine versus separately administered DTP-HBV and HIB vaccines for primary prevention of diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae B (HIB). Bar-On ES, Goldberg E, Hellmann S, Leibovici L. Cochrane Database Syst Rev; 2012 Apr 18; 2012(4):CD005530. PubMed ID: 22513932 [Abstract] [Full Text] [Related]
13. Immunogenicity of the pentavalent DTwP-HB-Hib vaccine (Shan-5) used in the Thai Expanded Program on Immunization compared to the hexavalent DTaP-HB-Hib-IPV and DTwP-HB-Hib (Quinvaxem) vaccines administered to infants at 2, 4, 6 months of age. Wanlapakorn N, Pruetarat N, Sarawanangkoor N, Phanphanit K, Srimuan D, Thatsanathorn T, Thongmee T, Posuwan N, Poovorawan Y. Vaccine; 2023 Jun 13; 41(26):3855-3861. PubMed ID: 37202270 [Abstract] [Full Text] [Related]